165 related articles for article (PubMed ID: 16464404)
1. Correlative studies in neuro-oncology trials: should they influence treatment?
Hegi ME; Stupp R
Curr Oncol Rep; 2006 Jan; 8(1):54-7. PubMed ID: 16464404
[TBL] [Abstract][Full Text] [Related]
2. Neuro-oncology: Implications of the molecular era.
Ruff MW; Uhm JH; Benarroch EE
Neurology; 2019 Mar; 92(12):568-574. PubMed ID: 30760635
[TBL] [Abstract][Full Text] [Related]
3. Incorporation of prognostic and predictive factors into glioma clinical trials.
Johnson DR; Galanis E
Curr Oncol Rep; 2013 Feb; 15(1):56-63. PubMed ID: 23125011
[TBL] [Abstract][Full Text] [Related]
4. Molecularly based management of gliomas in clinical practice.
Rudà R; Pellerino A; Magistrello M; Franchino F; Pinessi L; Soffietti R
Neurol Sci; 2015 Sep; 36(9):1551-7. PubMed ID: 26194534
[TBL] [Abstract][Full Text] [Related]
5. Biomarkers usher in era of personalized care for malignant glioma patients.
Chakravarti A; Palanichamy K; Bell EH
CNS Oncol; 2012 Sep; 1(1):3-6. PubMed ID: 25054291
[No Abstract] [Full Text] [Related]
6. Input of molecular analysis in medical management of primary brain tumor patients.
Idbaih A; Duran-Peña A; Bonnet C; Ducray F
Rev Neurol (Paris); 2015; 171(6-7):457-65. PubMed ID: 26026669
[TBL] [Abstract][Full Text] [Related]
7. Molecular Biology in Pediatric High-Grade Glioma: Impact on Prognosis and Treatment.
Rizzo D; Ruggiero A; Martini M; Rizzo V; Maurizi P; Riccardi R
Biomed Res Int; 2015; 2015():215135. PubMed ID: 26448930
[TBL] [Abstract][Full Text] [Related]
8. Prognostic relevance of miRNA-155 methylation in anaplastic glioma.
Schliesser MG; Claus R; Hielscher T; Grimm C; Weichenhan D; Blaes J; Wiestler B; Hau P; Schramm J; Sahm F; Weiß EK; Weiler M; Baer C; Schmidt-Graf F; Schackert G; Westphal M; Hertenstein A; Roth P; Galldiks N; Hartmann C; Pietsch T; Felsberg J; Reifenberger G; Sabel MC; Winkler F; von Deimling A; Meisner C; Vajkoczy P; Platten M; Weller M; Plass C; Wick W
Oncotarget; 2016 Dec; 7(50):82028-82045. PubMed ID: 27880937
[TBL] [Abstract][Full Text] [Related]
9. Circular RNAs: Functions and Prospects in Glioma.
Hao Z; Hu S; Liu Z; Song W; Zhao Y; Li M
J Mol Neurosci; 2019 Jan; 67(1):72-81. PubMed ID: 30460608
[TBL] [Abstract][Full Text] [Related]
10. An Innovative Fluorescent Semi-quantitative Methylation-specific PCR Method for the Determination of MGMT Promoter Methylation is Reflecting Intra-tumor Heterogeneity.
Nguyen A; Legrain M; Noel G; Coca A; Meyer Ea N; Schott R; Lasthaus C; Chenard MP; Gaub MP; Lessinger JM; Guenot D; Entz-Werle N
Curr Cancer Drug Targets; 2015; 15(7):624-40. PubMed ID: 26118907
[TBL] [Abstract][Full Text] [Related]
11. Decreased expression of miR-378 correlates with tumor invasiveness and poor prognosis of patients with glioma.
Li B; Wang Y; Li S; He H; Sun F; Wang C; Lu Y; Wang X; Tao B
Int J Clin Exp Pathol; 2015; 8(6):7016-21. PubMed ID: 26261592
[TBL] [Abstract][Full Text] [Related]
12. An NF-κB signature predicts low-grade glioma prognosis: a precision medicine approach based on patient-derived stem cells.
Ius T; Ciani Y; Ruaro ME; Isola M; Sorrentino M; Bulfoni M; Candotti V; Correcig C; Bourkoula E; Manini I; Pegolo E; Mangoni D; Marzinotto S; Radovic S; Toffoletto B; Caponnetto F; Zanello A; Mariuzzi L; Di Loreto C; Beltrami AP; Piazza S; Skrap M; Cesselli D
Neuro Oncol; 2018 May; 20(6):776-787. PubMed ID: 29228370
[TBL] [Abstract][Full Text] [Related]
13. Neuro-oncology in 2015: Progress in glioma diagnosis, classification and treatment.
Wen PY; Reardon DA
Nat Rev Neurol; 2016 Feb; 12(2):69-70. PubMed ID: 26782337
[No Abstract] [Full Text] [Related]
14. Precision Neuro-oncology: the Role of Genomic Testing in the Management of Adult and Pediatric Gliomas.
Ramkissoon LA; Britt N; Guevara A; Whitt E; Severson E; Sathyan P; Gay L; Elvin J; Ross JS; Brown C; Stogner-Underwood K; Mott R; Kram D; Strowd R; Lesser GJ; Ramkissoon SH
Curr Treat Options Oncol; 2018 Jun; 19(8):41. PubMed ID: 29931654
[TBL] [Abstract][Full Text] [Related]
15. Molecular neuro-oncology: a forward-looking perspective.
Wick W; O'Neill T
CNS Oncol; 2013 Nov; 2(6):491-3. PubMed ID: 25054819
[TBL] [Abstract][Full Text] [Related]
16. Satisfying your neuro-oncologist: a fast approach to routine molecular glioma diagnostics.
Hench J; Bihl M; Bratic Hench I; Hoffmann P; Tolnay M; Bösch Al Jadooa N; Mariani L; Capper D; Frank S
Neuro Oncol; 2018 Nov; 20(12):1682-1683. PubMed ID: 30169880
[No Abstract] [Full Text] [Related]
17. Large Animal Models of Glioma: Current Status and Future Prospects.
Hicks WH; Bird CE; Pernik MN; Haider AS; Dobariya A; Abdullah KG; Aoun SG; Bentley RT; Cohen-Gadol AA; Bachoo RM; Mickey BE; Pascual JM; El Ahmadieh TY
Anticancer Res; 2021 Nov; 41(11):5343-5353. PubMed ID: 34732404
[TBL] [Abstract][Full Text] [Related]
18. CD133 in brain tumor: the prognostic factor.
Li B; McCrudden CM; Yuen HF; Xi X; Lyu P; Chan KW; Zhang SD; Kwok HF
Oncotarget; 2017 Feb; 8(7):11144-11159. PubMed ID: 28055976
[TBL] [Abstract][Full Text] [Related]
19. Updates from the 2013 Society for Neuro-Oncology annual and World Federation for Neuro-Oncology quadrennial meeting.
Lukas RV; Amidei C
Tumori; 2014; 100(3):358-62. PubMed ID: 25076251
[TBL] [Abstract][Full Text] [Related]
20. New frontiers in the treatment of malignant glioma.
Macdonald DR
Semin Oncol; 2003 Dec; 30(6 Suppl 19):72-6. PubMed ID: 14765391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
